Archives of the Turkish Society of Cardiology
Cholesterol Embolization Syndrome: An Increasing But Still Underdiagnosed Disease [Turk Kardiyol Dern Ars]
Turk Kardiyol Dern Ars. 2002; 30(10): 647-651

Cholesterol Embolization Syndrome: An Increasing But Still Underdiagnosed Disease

Hülya Akhan KAŞIKÇIOĞLU1, Neşe ÇAM1

Cholesterol embolization syndrome is a multisystem disease resulting from cholesterol crystal embolization to many organs, including the kidney, skin, brain, eye, gastrointestinal tract and extremities. Vascular surgery, vascular radiological interventions, thrombolytic therapy and anticoagulation have been detected as triggering factors. Cholesterol atheromatous embolism is a common, but often unrecognized problem due to the difficulties of the diagnosis, absence of effective therapeutic regimen and high mortality rate. Because of the population at risk for cholesterol embolism is increasing and the disease is frequently iatrogenic in origin, we should expect to detect cholesterol embolism more frequent as a cause of acute renal failure and other clinical manifestations of the disease in future. In this review we focused on the clinical manifestations, diagnosis and therapeutic options of cholesterol embolization syndrome.


How to cite this article
Hülya Akhan KAŞIKÇIOĞLU, Neşe ÇAM. Cholesterol Embolization Syndrome: An Increasing But Still Underdiagnosed Disease. Turk Kardiyol Dern Ars. 2002; 30(10): 647-651
© Copyright 2020 Archives of the Turkish Society of Cardiology
LookUs & Online Makale